Form 4 for RMD ResMed|
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-11 · accession 0001127602-22-025657 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-15 | 2022-11-11 | RMD | Farrell Michael J. | CEO | F - Tax | $225.18 | -8,630 | 414.0K | -2% | -$1.94M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-11 | F | D | 3,233 | $225.18 | 417,062 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2022-11-11 | F | D | 2,359 | $225.18 | 420,295 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2022-11-11 | F | D | 3,038 | $225.18 | 414,024 | D | — | — |